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Abstract 
A quantitative structure activity relationship analysis was applied to a library of 51 
benzylacetamide derivatives with anticonvulsant activity. The molecular structures of 51 
compounds were optimized with the Semiempirical Method PM6 (Parametric Method-6) 
included in the MOPAC2009 software. The optimized structures of all the examined 
compounds were represented by 1497 DRAGON-type descriptors. Using multiple linear 
regression (MLR), the influence of constitutional, topological, electronic, physicochemical and 
quantum molecular descriptors on the activity was investigated. The validation of models were 
performed through the leave-one-out cross technique in conjunction with external validation. 
From different types of molecular descriptors, six new QSAR models were developed. The 
models using 0D descriptors (constitutional descriptors) and quantum descriptors do not have 
high statistical quality. The combination of 2D and 3D descriptors produce a model of high 
predictive quality (Rcal= 0.888; Scal= 0.195; Rval= 0.814; Sval=0.431; Rloo=0.867; 
Sloo=0.212). Results show the important role of electronic and topologic features of molecules 
on their anticonvulsant activity in relative to constitutional parameters. 
 
1. Introduction 
 
 The search for safe and more potent anticonvulsant remains a drug design priority and a 
wide variety of compound has been synthesized for this purpose. Previous comparisons of the 
structural characteristics of anticonvulsant drug have identified a common pattern defined by 
a nitrogen heteroatomic system, at least one carbonyl group, together with two or one phenyl 
group [1-3]. On the other hand, the role of hydrogen bond in the docking process has been 
largely discussed, although in spite of the efforts no correlation has been found [3]. 
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 Quantitative structure-activity relationship (QSAR) studies have received widespread 
attention as a powerful tool to better direct the rational synthesis of new drugs with 
anticonvulsant activity [4-6]. 
 We developed some structure-activity relationship studies on compounds with 
antiepileptic activity [4,7,8]. In 2005, Jin et al [9] used QSAR methodology to elucidate the 
structure correlates of anticonvulsant activity in the series of 35 benzylacetamide derivatives 
shown by Kohn et al [10]. Using the method of partial least-squares regression (PLSR) in 
conjunction with leave-one-out cross-validation, the influence of 31 topological, electronic, 
physicochemical, and structural molecular descriptors on anticonvulsant activity was 
investigated. A QSAR model of the logED50 in the MES test (maximal electroshock seizure) 
was established as a function of the following seven molecular descriptors: the Wiener index 
on distance code (Wmean), the mean information index on atomic composition (rIac), the 
partial charge at the C-terminal carbonyl carbon (qCC), the sum of partial charge in the  
substituent (qtotal), the number of hydrogen bond donor and acceptor in the  substituent 
(Hd and Ha), and the calculated value of squared n-octanol/water partition coefficient, 
with Rcal=0.77 and Rval=0.63. This model provided statistical support for the validity of the 
proposed anticonvulsant pharmacophore. From a structural perspective, favorable bioactivity 
was correlated with: highly branched, cyclic  substituents (indicated by Wmean and rIac); 
the presence of   substituents hydrogen-bond acceptors (from Ha); the absence of 
hydrogen-bond donor (Hd); and, the presence of electron-withdrawing substituents at either 
the -position or the benzyl moiety (from the qCC term). 
 Recently, others acetamido-N-benzylacetamide derivatives were shown to be a 
promising novel anticonvulsant class [11-14]. The putative benzylacetamide anticonvulsant 
pharmacophore (Fig. 1) consists of: a vicinal diamine linked; an oxygen atom on the ethylene 
chain bridging two amino groups; and an aromatic ring one carbon removed from an amine 
group. 
 
 
 
 
 
Figure 1: Pharmacophoric pattern for -substituents acetamido-N-benzylacetamide compounds. 
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  This paper proposes new QSAR models to elucidate the structural correlates of 
anticonvulsant activity in a serie of 51 -substituents acetamido-N-benzylacetamide 
compounds [9-14].  In order to obtain the effects of the structural parameters on the activity, 
QSAR analysis with different type of molecular descriptors was operated. 
 The search for the best structure – activity models is carried out by means of the 
replacement method (RM) [15-17] variable subset selection technique and multiple linear 
regression (MLR). 
 
2. Material and methods 
2.1 Experimental data 
 All acetamido-N-benzylacetamide compounds of this study were synthesized and the 
racemates were pharmacologically evaluated as previously described [9,10]. The parameter of 
activity (ED50 in mg/kg) represents the dose at which 50% of individuals reach the desired 
effect. This is generally obtained in the "Anticonvulsant Selection Project" (ASP) by the 
experimental method "Maximal electroshock seizure" (MES) [18]. For modeling purposes, 
we use log10ED50 to get a more standardized property. 
 
2.2 Geometry optimization and molecular descriptors calculation 
 The structures of all the examined compounds are optimized with the Semiempirical 
Method PM6 (Parametric Method-6) [19] included in the MOPAC2009 software [20]. By 
means of the software Dragon [21] we calculate a set of 1497 molecular descriptors [22-25] 
(Table 1). Additionally, some quantum chemical descriptors obtained from a semiempirical 
molecular modeling study were added to the classical descriptors. 
Table 1: Classification of molecular descriptors calculated by Dragon. 
Type of Descriptors 
Numbers of 
descriptors 
Classification 
Constitutional Descriptors 47 0D 
Functional Groups 121 
1D 
 
Atom Centred Fragments 120 
Empirics Descriptors 3 
Properties  3 
Descriptors topological 266 2D 
 Molecular walk counts 21 
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 BCUT Descriptors 64 
Galvez Charge Index 21 
2D autocorrelation 96 
Descriptors of Charge 14 
3D 
 
Aromatic index 4 
Molecular profiles of Randic 41 
Geometry Descriptors 70 
RDF Descriptors 150 
3D-Morse Descriptors 160 
WHIM descriptors 99 
GATEWAY Descriptors 197 
 
Quantum: Heat of formation, Energy of the HOMO, LUMO and HOMO-LUMO difference, 
Molecular area, Electronic energy, Total energy, Ionization potential, Core-core repulsion and 
Molecular volume. 
Molecular descriptors were then removed to reduce the number of highly correlation. 
Therefore, the set of descriptors contains D =1239 variables. 
 
2.3 Model Development 
 To establish a predictive structure–activity relationship, it is necessary to search for a 
subset with the best molecular descriptors that reflect the structural features of compounds 
that best correlate with the biological activity under study. The QSAR models established are 
obtained via search of molecular descriptors by MLR using RM. 
 The RM is a powerful variable subset selection approach [15-17] and an efficient 
optimization tool that generates multi-parametric linear regression-based QSAR by searching 
the set d of D descriptors for an optimal subset d of d << D descriptors with minimum model's 
standard deviation (S). We used the computer Matlab 7.0 [26] system for all of our 
calculations by multivariable linear regression. 
 On the other hand, the Kubinyi function FIT [27-29] is used to get the optimum number 
of descriptors (dopt) of each linear regression established. FIT function achieves a maximum 
value (dmax) deduced from the plot of the FIT vs. d. 
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 2.4 Validation techniques 
 A next step of current analysis is to verify the validation (predictive capability) of the 
QSAR relationships established on a calibration set of chemical structures. One would be able 
to verify that the linear relationships established behave correlatively and would also function 
well for the prediction of new data, not contemplated during the training stage of the model. 
 The predictive power of the models is explored using the Leave-One-Out (loo) Cross-
Validation procedures [30,31]. Also, the models are then subjected to a more realistic external 
validation using a test set containing some new compounds that have not been contemplated 
during the model development; these structures are selected in such a way that they share 
chemical functional groups that are similar to the training set molecules. 
 
3. Results and discussion 
 The chemical structure and biological activity of the molecules used in this study are 
shown in the Table 2. As it shown, the molecules possess a wide variety of substituent with 
different hydrophobic and electronic properties and their biological activity log ED50 is varied 
between 0.544 and 1.994. The most active compound has a CH2OCH3 group at R1 and a para-
CH2=CH2 group on the phenyl ring. The least active one is containing a N(H)Ph(3-NH2) at R1. 
 
 
Table 2: Experimental and predicted by QSAR models anticonvulsant activity. 
    
Log10ED50 
Pred 
ID R1 R2 Log10ED50 Exp b 
Eq. 1 Eq. 2 Eq. 3 Eq. 4 Eq. 5 Eq. 6 
1 CH3 Ph 1.884 1.568 1.597 1.729 1.416 1.556 1.732 
2 CH3 Ph-m-F 1.889 1.568 1.597 1.674 1.892 1.492 1.819 
3 2-Furanyl Ph-o-F 1.602 1.256 1.408 1.440 1.612 1.221 1.394 
4a 2-Furanyl Ph-m-F 1.124 1.256 1.408 1.404 1.482 1.166 1.349 
5 2-Furanyl Ph-p-F 1.104 1.256 1.408 1.279 1.422 1.157 1.200 
6 2-Furanyl 2,5-F2C6H3 1.377 1.256 1.408 1.230 1.480 1.205 1.130 
7 2-Furanyl 2,6-F2C6H3 1.799 1.256 1.408 1.500 1.515 1.152 1.474 
8 3-Allyl Ph 1.526 1.392 1.389 1.225 1.360 1.324 1.303 
9 2-Tetrahydrofuranyl Ph 1.713 1.785 1.805 1.521 1.755 1.259 1.792 
10 Ph Ph 1.308 1.594 0.973 1.115 1.296 1.139 1.398 
11a 2-Furanyl Ph 1.013 1.256 1.408 1.381 1.072 1.274 1.306 
12 Furanyl-5-CH3 Ph 1.283 1.256 1.597 1.091 1.122 1.302 1.218 
13 2-Pyrrolyl Ph 1.207 1.618 1.408 1.607 1.300 1.530 1.589 
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a Compound used as external test set. 
b Dates experimental previously published by other authors [9-14]  
14 2-Pyrrolyl-5-CH3 Ph 1.562 1.618 1.597 1.296 1.026 1.575 1.462 
15a 2-Thienyl Ph 1.651 1.618 1.408 1.699 1.504 1.263 1.551 
16 3-Thienyl Ph 1.943 1.618 1.843 1.839 1.864 1.331 1.540 
17 1-Pyrrole Ph 1.904 1.618 1.843 1.707 1.583 1.479 1.565 
18 1-Pyrazole Ph 1.217 1.618 1.408 1.406 1.283 1.320 1.354 
19 2-Pyridyl Ph 1.033 1.088 0.973 1.000 1.231 1.157 1.192 
20 C(S)NH2 Ph 1.937 1.392 1.965 1.843 1.781 1.695 1.896 
21 NHCH2CH3 Ph 1.627 1.568 1.597 1.440 1.648 1.396 1.551 
22 N(CH3)2 Ph 1.656 1.568 0.973 1.879 1.766 1.611 1.852 
23 N(CH3)OH Ph 1.477 1.206 1.687 1.728 1.620 1.400 1.511 
24 NPhNH2 Ph 1.631 1.594 0.973 1.741 1.510 1.197 1.824 
25 OH Ph 1.898 1.206 1.687 1.894 1.757 1.537 2.128 
26a OCH2CH3 Ph 1.792 1.206 1.597 1.443 1.977 1.332 1.465 
27 CH2OCH3 Ph 0.919 1.206 0.973 0.842 1.357 1.329 1.137 
28 CH2OCH2CH3 Ph 1.230 1.206 1.597 1.128 1.091 1.243 1.238 
29 2-Pyrazinyl Ph 1.170 1.088 0.973 0.927 1.350 1.181 1.185 
30 2-Pyrimidyl Ph 0.908 1.088 0.973 0.936 1.069 1.259 0.880 
31 2-Oxazole Ph 1.021 1.256 0.973 1.308 1.145 1.186 1.131 
32 2-Thiazole Ph 1.079 1.618 0.973 1.629 1.326 1.178 1.363 
33 N(H)Ph(3-NH2) Ph 1.994 1.594 1.965 1.706 1.674 1.480 1.895 
34 2-Furanyl 5-Pyridyl 1.477 1.256 1.408 1.381 1.149 1.250 1.326 
35 CH2OCH3 Ph-m-F 0.839 1.206 0.973 0.865 0.695 1.325 0.679 
36 CH2OCH3 Ph-p-F 0.623 1.206 0.973 0.741 0.610 1.351 0.569 
37 CH2OCH3 Ph-p-OCF3 0.556 0.844 0.973 0.577 0.550 1.010 0.640 
38a CH2OCH3 Ph-p-CH2OCF3 1.041 0.844 0.973 0.923 1.121 1.161 0.907 
39 CH2OCH3 Ph-p-CH2CH2CH3 0.929 1.206 0.973 0.991 1.137 1.172 0.922 
40 CH2OCH3 Ph-p-CH3 0.863 1.206 0.973 0.834 1.022 1.439 0.865 
41 CH2OCH3 Ph-p-CH2CH2CH2OCH3 1.301 0.844 1.389 1.396 1.049 0.940 1.191 
42 CH2OCH3 Ph-p-CH2=CH2 0.544 0.853 0.973 0.665 0.821 1.351 0.911 
43 CH2OCH3 Ph-p-C6H5 0.903 1.055 0.973 1.129 1.196 1.051 1.017 
44 CH2OCH3 Ph-p-CCCH2 OCH3 1.000 0.667 0.973 1.243 0.957 1.042 1.014 
45a CH2OCH3 Ph-p-Cl 0.699 1.206 0.973 0.861 0.590 1.324 0.842 
46 CH2OCH3 Ph-p-Br 0.940 1.206 0.973 0.967 1.110 1.278 0.827 
47 CH2OCH3 Ph-p-I 1.204 1.206 0.973 1.169 1.120 1.256 1.209 
48 NHOCH3 Ph 0.792 1.206 0.973 0.883 0.817 1.379 0.844 
49 NCH3OCH3 Ph 0.826 1.206 0.973 1.004 0.789 1.453 0.855 
50a 2-Furanyl Ph-p-CH3 1.639 1.256 1.408 1.255 1.500 1.320 1.358 
51 2-Furanyl Ph-p-CF3 1.358 1.256 1.408 1.548 1.496 0.991 1.617 
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 3.1 MLR analysis 
 
 MLR analysis was employed to model the structure-activity relationship with different 
set of descriptors.  The resulted regression equations are summarized in Table 3. The first 
equation (eq. 1) was derived by using the 0D descriptors (constitutional descriptors). This 
equation which does not have high statistical quality (Rcal=0.606 and Scal=0.338), however, 
describes that number of multiple bonds (nBM), number of rings (nCIC), number of oxygen 
atoms (nO) and number of benzene (nBnz) affect on the anticonvulsant activity acetamido-N-
benzylacetamide compounds.. 
 The second equation (eq. 2) shows that the 1D descriptors could explain the structure-
anticonvulsant activity relationship better than that of constitutional descriptors (Rcal=0.794 
and Scal=0.258). The number of hydrogen attached to a carbon sp3, sp2, sp (H-048), number 
of hydrogen attached to a heteroatom (H-050), number of oxygen alcohol (O-056) and 
number of Ar-NH2 or X-NH2 (N-069) are the parameters of the equation. Some of these 0D 
and 1D descriptors (nO, nBnz, H-050 and N-069) are present to the common pattern 
previously showed. 
 According to the statistical parameters of eq. 3, the 2D descriptors are able to 
characterize better the anticonvulsant activities of compounds. This four-parametric equation 
has correlation coefficient and deviation standard equal to 0.855 and 0.220 respectively.  The 
notation for de molecular descriptors involved in the QSAR models is shown in Table 4. The 
model obtained with 3D descriptors, eq. 4, has similar statistical parameters than eq. 3 
(Rcal=0.860 and Scal=0.216). This also is a four-parametric equation and the molecular 
descriptors participating are: a RDF descriptors (RDF070m), a WHIM descriptors (G1u) and 
two GATEWAY type of descriptors (HATS8u and R3e), Table 4. 
 The eq. 5 was obtained from 11 quantum molecular descriptors. The high deviation 
standard and low regression coefficient of this equation reveal that the activity is not affected 
for these parameters. The two-parametric equation indicated the poor dependence of the 
activity on the ionization Potential, molecular volume and the others quantum descriptors. 
Finally, the best statistical parameters were obtained when all type of molecular descriptors 
were used to build the QSAR model, eq. 6. The four descriptors from two different types of 
descriptors were used in this equation, three 2D descriptors and one from 3D family. This 
equation, which has high statistical quality (Rcal=0.888 and Scal=0.195), demonstrates that 
characteristic 2D and 3D of the molecules are major factors controlling the binding of the 
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 acetamido-N-benzylacetamide derivative to the receptors. It is noted, that the constitutional 
and functional groups descriptors were not appeared in the final QSAR model. It can be 
explained compared the equation 3 and 4 with the equations 1 and 2. The correlation between 
the constitutional (0D descriptors) and functional groups (1D descriptors) is not as high as 
topological (2D descriptors) and Gateway (3D descriptors). The QSAR model proposed by 
Jin at al. (Rcal=0.77 and Rval=0.63) could be compared in quality with the model of 1D 
descriptors (eq. 2). However, the model obtained from 2D and 3D descriptors have higher 
quality and a more predicted power. 
 
Table 3: MLR-QSAR models results. 
 
 
 
Eq. Model and Statistical Parameters  
1 log10ED50=2.621 (0.419) -0.176 (0.054) 'nBM' + 0.579 (0.190) 'nCIC' -0.362 
(0.087) 'nO'+  0.505 (0.242) 'nBnz' 
N= 51 Rcal= 0.606   Scal= 0.338  Rval= 0.425  Sval=0.657 Rloo=0.511 Sloo= 
0.368 
0D 
2 log10ED50=0.972 (0.052) + 0.435 (0.071) 'H-048' + 0.208 (0.032) 'H-052' + 0.714 
(0.190) 'O-056' + 0.992 (0.190) 'N-069' 
N= 51 Rcal=  0.794  Scal= 0.258    Rval= 0.761   Sval= 0.483   Rloo= 0.747   
Sloo=0.283 
1D 
3 log10ED50=9.774 (0.802) -39.058 (7.642) 'PW5'  - 2.510 (0.397) 'BEHv7' + 0.091 
(0.012) 'ATS7p' -1.2474 (0.255) 'GATS7v' 
N= 51 Rcal= 0.855  Scal=  0.220    Rval= 0.695   Sval=0.513    Rloo= 0.823   
Sloo= 0.241 
2D 
4 log10ED50=-7.350 (1.213) + 0.073 (0.018) 'RDF070m' + 37.469 (5.872) 'G1u' - 
3.395 (0.546) 'HATS8u' + 2.275 (0.327) 'R3e' 
N= 51 Rcal= 0.860   Scal= 0.216    Rval= 0.903   Sval= 0.335    Rloo= 0.833   
Sloo= 0.235 
3D 
5 log10ED50=8.282 (2.576) -0.518 (0.224) 'Pioniz' -0.006 (0.002) 'Vol' 
 
N= 51 Rcal= 0.401   Scal= 0.381   Rval= 0.318   Sval=0.484    Rloo= 0.405   
Sloo= 0.267 
Quantum 
6 log10ED50=3.152 (0.665) - 50.488 (6.699) 'PW5' + 0.066 (0.009) 'ATS7p' -1.073 
(0.231) 'GATS7v' + 5.028 (0.631) 'HATS3u' 
N= 51 Rcal= 0.888   Scal= 0.195   Rval= 0.814   Sval=0.431    Rloo=0.867   
Sloo=0.212 
All 
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 Table 4: Notation for molecular descriptors involved in the QSAR models. 
 
Descriptors Classification a Type Brief description 
nBM 0D Constitutional 
Descriptors 
Number of multiple bonds  
nCIC   Number of rings  
nO   Number of oxygen atoms  
nBnz   Number of benzene  
H-048 1D Atom-center 
fragments 
number of hydrogen attached  
to a carbon sp3, sp2, sp  
H-052   H attached to CO (sp3) with 1X attached to next 
C.  
O-056   alcohol  
N-069   Ar-NH2 / X-NH2  
PW5 2D Topologic descriptors Path/walk 5 –Randic shape index.  
BEHv7  BCUT descriptors  Highest eigenvalues n. 7 of Burner matrix / 
weighted by atomic Van der Waals.  
ATS7p  2D Autocorrelation  Broto-Moreau autocorrelation of a topological 
structure - lag 7 / weighted by atomic 
polarizabilities.  
GATS7v   Geary autocorrelation - lag 7 / weighted by 
atomic Van der Waals volumes. 
RDF070m 3D Radial distribution 
Funtion  
Radial Distribution Function - 7.0 / weighted by 
atomic masses.  
G1u  WHIM descriptors  1st component symmetry directional WHIM 
index / unweighted.  
HATS8u  GATEWAY Leverage-weighted autocorrelation of lag 8 / 
unweighted. 
R3e   R autocorrelation of lag 3 / weighted by atomic 
sanderson electronegativities.  
HATS3u   Leverage-weighted autocorrelation of lag 3 / 
unweighted. 
Pioniz  Quantum Ionization Potential 
Vol   Molecular Volume  
 
a Classification given by the software Dragon 
 
 The correlation coefficient between the descriptors is listed in Table 5. All the non-
diagonal elements were less than 0.83, indicating that the co-linear situation between different 
descriptors and redundant information included in the set of descriptors are low. 
 
Table 5: Correlation matrix for descriptors of  the QSAR models. 
 
Eq.  nBM nCIC nO nBnz 
1 
nBM 1.000 0.831 0.428 0.584 
nCIC  1.000 0.348 0.286 
nO   1.000 0.220 
nBnz    1.000 
      
  H-048 H-052 O-056 N-069 
2 
H-048 1.000 0.280 0.117 0.117 
H-052  1.000 0.098 0.098 
O-056   1.000 0.041 
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 N-069    1.000 
      
  PW5 BEHv7 ATS7p GATS7v 
3 
PW5 1.000 0.649 0.729 0.078 
BEHv7  1.000 0.824 0.155 
ATS7p   1.000 0.025 
GATS7v    1.000 
      
  RDF070m G1u HATS8u R3e 
4 
RDF070m 1.000 0.339 0.067 0.080 
G1u  1.000 0.096 0.093 
HATS8u   1.000 0.215 
R3e    1.000 
      
  Pioniz Vol   
5 Pioniz 1.000 0.487   
Vol  1.000   
      
  PW5 ATS7p GATS7v HATS3u 
6 
PW5 1.000 0.729 0.078 0.296 
ATS7p  1.000 0.025 0.487 
GATS7v   1.000 0.324 
HATS3u    1.000 
 
 
3.2 Validation of generated QSAR models 
 
 To test the ability of the model for predicting log10ED50 values of a set of molecules, 
the leave-one-out cross validation and external validation were performed. To the external 
validation a subset was used as a test set. Thus, seven molecules (13.7%) out of the 51 data 
set of molecules were used to test the model. The statistical parameters of the different model 
(Table 3) indicate that the eq. 4 and eq. 6 QSAR models have stable predictive power within 
the current experimental data set, see Fig 2. 
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Figure 2: Experimental versus predicted anticonvulsant activity for the six QSAR models. 
 
3.3 Descriptor contribution analysis 
 
 Descriptors used in the generated of different QSAR models were classified in tables 4 
and 5. The contributions of each descriptor (standardized regression coefficients) in the MLR 
models were determined, and are provided in Table 6. The significance of the descriptors 
involved in each model decreases in the following order: 
 
Equation 1: 
nBM (0.926) >nCIC (0.715) > nO (0.540) > nBnz (0.335) 
 
Equation 2: 
H-052 (0.604) > H-048 (0.582) > N-069 (0.476) > O-056 (0.342) 
 
Equation 3: 
ATS7p (1.085) > BEHv7 (0.906) > PW5 (0.579) > GATS7v (0.395) 
 
Equation 4: 
R3e (0.537) > G1u (0.516) > HATS8u (0.480) > RDF070m (0.316) 
0
0.5
1
1.5
2
2.5
0 0.5 1 1.5 2 2.5
Log10ED50 exp
Lo
g 1
0E
D 5
0 P
re
d
Eq. 5
0
0.5
1
1.5
2
2.5
0 0.5 1 1.5 2 2.5
Log10ED50 exp
Lo
g 1
0E
D 5
0 P
re
d
Eq. 6
Eq. 3
0
0.5
1
1.5
2
2.5
0 0.5 1 1.5 2 2.5
Log10ED50 exp
Lo
g 1
0E
D 5
0 P
re
d
Eq. 4
0
0.5
1
1.5
2
2.5
0 0.5 1 1.5 2 2.5
Log10ED50 exp
Lo
g 1
0E
D 5
0 P
re
d
-755-
 Equation 5: 
Vol (0.431) > Pioniz (0.349) 
 
Equation 6: 
ATS7p (0.789) > PW5 (0.748) > HATS3u (0.669) > GATS7v (0.340) 
 
Table 6: Standardized regression coefficients for descriptors of QSAR models. 
Eq.     
1 nBM nCIC nO nBnz 
0.926 0.715 0.540 0.335 
2 H-048 H-052 O-056 N-069 
0.582 0.604 0.342 0.476 
3 PW5 BEHv7 ATS7p GATS7v 
0.579 0.906 1.085 0.395 
4 RDF070m G1u HATS8u R3e 
0.316 0.516 0.480 0.537 
5 Pioniz Vol   
0.349 0.431   
6 PW5 ATS7p GATS7v HATS3u 
0.748 0.789 0.340 0.669 
 
 For the case of eq. 1 nBM is the most important variable of this model. nBM represents 
the number of multiple bonds in the molecules. The signs of the regression coefficients 
suggest that the presence the rings like benzene and decreasing the number multiple bonds are 
favorable to the activity. 
 In the eqs. (2, 3, 4, 5) the most important descriptors are H-052, ATS7p, R3e, Vol 
respectively.  The positive signs of the regression coefficients of H-052, ATS7p, R3e indicate 
that increasing in their values would lead to lower predicted ED50 values. 
 The descriptor ATS7p is the most important variable in the eqs. 3 and 6. The ATS7p is 
2D autocorrelation descriptors and represent Broto-Moreau autocorrelation of a topological 
structure-lag 7 / weighted by atomic polarizabilities. PW5 is a topological descriptor related to 
molecular shape. It is other important variable descriptor in eq.6 and belongs to 2D 
descriptors to. The presence of three 2D descriptors in de model (ATS7p, PW5 and GATS7v) 
suggests that these types of descriptors are able to characterize better the anticonvulsant 
activities of compounds. 
 It should be noted from Table 6 that the difference in descriptor contribution between 
the descriptors in each models is not significant, indicating that all descriptors are 
indispensable in generating the different predictive models. 
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 4. Conclusions 
 A QSAR analysis has been applied to a data set of 51 acetamido-N-benzylacetamide 
derivatives. Six QSAR models were performed used different families of molecular 
descriptors. The results suggest that of quantum descriptors used in the model has a poor 
correlation with the activity. The models obtained with constitutional descriptors present an 
acceptable correlation with the anticonvulsant activity, while the models with 2D and 3D 
descriptors are of higher quality. Finality, the combination of 2D and 3D descriptors produce 
a better model to predict the anticonvulsant activity on this family of compounds. The QSAR 
results found are able to achieve a higher quality model when compared to models obtained 
by other authors. Also, this study demonstrated the more important role of electronic and 
topologic features of molecules on their anticonvulsant activity in relative to constitutional 
parameters. 
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